1. Home
  2. NCMI vs QTRX Comparison

NCMI vs QTRX Comparison

Compare NCMI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$3.87

Market Cap

414.7M

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$6.58

Market Cap

352.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCMI
QTRX
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
414.7M
352.7M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
NCMI
QTRX
Price
$3.87
$6.58
Analyst Decision
Strong Buy
Hold
Analyst Count
4
3
Target Price
$6.88
$10.33
AVG Volume (30 Days)
414.2K
804.7K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
3.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$236,300,000.00
$130,203,000.00
Revenue This Year
$3.66
N/A
Revenue Next Year
$12.17
$28.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.81
$4.05
52 Week High
$7.25
$12.41

Technical Indicators

Market Signals
Indicator
NCMI
QTRX
Relative Strength Index (RSI) 36.12 44.17
Support Level $3.98 $7.44
Resistance Level $4.12 $7.55
Average True Range (ATR) 0.14 0.41
MACD -0.02 -0.15
Stochastic Oscillator 1.09 4.38

Price Performance

Historical Comparison
NCMI
QTRX

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Share on Social Networks: